Skip to main content
Fig. 1 | Trials

Fig. 1

From: Non-concealed placebo treatment for menopausal hot flushes: Study protocol of a randomized-controlled trial

Fig. 1

Schedule of enrolment, intervention, and assessment according to SPIRIT. Post post-treatment, wk week, FU follow-up, OLP open-label placebo, HFRS Hot Flush Rating Scale, WHQ Women’s Health Questionnaire, PGIC Patient Global Impression of Change, MRS Menopause Rating Scale, MHQ Menopause Health Questionnaire, AUDIT-C Alcohol Use Disorders Identification Test—Consumption, PHQ Patient Health Questionnaire, PSS Perceived Stress Scale, LOT-R Life Orientation Test—Revised, GASE Generic Assessment of Side Effects. Hot flushes are assessed ambulatory via the hot flush diary. *At baseline, health-related quality of life and expectations are assessed before and after the allocation, respectively. †The fourth study visit and the 8-week follow-up assessment takes place for the OLP 8wk and OLP 4wk groups only. ‡For the second allocation, the OLP group is further divided into the OLP 8wk and the OLP 4wk groups. §The interview is conducted at week 8 or later

Back to article page